Literature DB >> 16198599

Mice deficient in the chemokine receptor CXCR4 exhibit impaired limb innervation and myogenesis.

Veysel Odemis1, Elke Lamp, Gita Pezeshki, Barbara Moepps, Karl Schilling, Peter Gierschik, Dan R Littman, Jürgen Engele.   

Abstract

The chemokine CXCL12/SDF-1 and its receptor CXCR4 regulate the development and the function of the hematopoietic system and control morphogenesis of distinct brain areas. Here, we demonstrate that inactivation of CXCR4 results in a massive loss of spinal cord motoneurons and dorsal root ganglion neurons and, subsequently, in a reduced innervation of the developing mouse fore- and hindlimbs. However, only the death of sensory neurons seems to be a direct consequence of receptor inactivation as suggested by the observations that DRG neurons, but not motoneurons, of wild-type animals express CXCR4 and respond to CXCL12 with an increase in cell survival. In contrast, the increased death of motoneurons in CXCR4-deficient animals seems to result from impaired limb myogenesis and a subsequent loss of muscle-derived neurotrophic support. In summary, our findings unravel a previously unrecognized complex role of CXCL12/CXCR4 in the control of limb neuromuscular development.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16198599     DOI: 10.1016/j.mcn.2005.07.019

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  35 in total

1.  Chemokine expression and control of muscle cell migration during myogenesis.

Authors:  Christine A Griffin; Luciano H Apponi; Kimberly K Long; Grace K Pavlath
Journal:  J Cell Sci       Date:  2010-08-24       Impact factor: 5.285

Review 2.  Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.

Authors:  Brice Korkmaz; Marshall S Horwitz; Dieter E Jenne; Francis Gauthier
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

Review 3.  CXCL12 signaling in the development of the nervous system.

Authors:  Divakar S Mithal; Ghazal Banisadr; Richard J Miller
Journal:  J Neuroimmune Pharmacol       Date:  2012-01-21       Impact factor: 4.147

Review 4.  Multiple roles of chemokine CXCL12 in the central nervous system: a migration from immunology to neurobiology.

Authors:  Meizhang Li; Richard M Ransohoff
Journal:  Prog Neurobiol       Date:  2007-11-26       Impact factor: 11.685

5.  Knockdown of CXCL14 disrupts neurovascular patterning during ocular development.

Authors:  Ana F Ojeda; Ravi P Munjaal; Peter Y Lwigale
Journal:  Dev Biol       Date:  2017-01-15       Impact factor: 3.582

6.  SDF-1 enhances wound healing of critical-sized calvarial defects beyond self-repair capacity.

Authors:  Qiming Jin; William V Giannobile
Journal:  PLoS One       Date:  2014-05-06       Impact factor: 3.240

7.  CXCR4 expression is elevated in glioblastoma multiforme and correlates with an increase in intensity and extent of peritumoral T2-weighted magnetic resonance imaging signal abnormalities.

Authors:  Charles B Stevenson; Moneeb Ehtesham; Kathryn M McMillan; J Gerardo Valadez; Michael L Edgeworth; Ronald R Price; Ty W Abel; Khubaib Y Mapara; Reid C Thompson
Journal:  Neurosurgery       Date:  2008-09       Impact factor: 4.654

8.  The CXCR4/SDF1 axis improves muscle regeneration through MMP-10 activity.

Authors:  Miriam Bobadilla; Neira Sainz; Gloria Abizanda; Josune Orbe; José Antonio Rodriguez; José Antonio Páramo; Felipe Prósper; Ana Pérez-Ruiz
Journal:  Stem Cells Dev       Date:  2014-03-14       Impact factor: 3.272

Review 9.  Chemokine receptor CXCR4 as a therapeutic target for neuroectodermal tumors.

Authors:  Hyunsuk Shim; Shinya Oishi; Nobutaka Fujii
Journal:  Semin Cancer Biol       Date:  2008-11-25       Impact factor: 15.707

10.  COUP-TFII regulates satellite cell function and muscular dystrophy.

Authors:  Xin Xie; Sophia Y Tsai; Ming-Jer Tsai
Journal:  J Clin Invest       Date:  2016-09-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.